New devices to reduce arsenic in drinking water
Novel filtration devices for iAs reduction
['FUNDING_OTHER'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-10939014
This study is working on new filters to help families who get their drinking water from private wells by making it safer and reducing harmful arsenic levels, so everyone can have clean water to drink.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-10939014 on ClinicalTrials.gov |
What this research studies
This research focuses on developing innovative filtration devices to effectively reduce inorganic arsenic (iAs) levels in drinking water sourced from private wells. Given that many households rely on these wells, which are often unregulated and can contain harmful contaminants, the project aims to create a membrane technology that overcomes the limitations of current filtration methods. The approach involves addressing the inadequate removal of the most toxic form of arsenic and improving water productivity, ensuring safer drinking water for communities. By collaborating with local communities, the research seeks to implement practical solutions that can be easily adopted.
Who could benefit from this research
Good fit: Ideal candidates for this research are families with children who rely on private well water that may be contaminated with inorganic arsenic.
Not a fit: Patients who do not use private well water or who have access to regulated municipal water supplies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the safety of drinking water for millions of people, reducing health risks associated with arsenic exposure.
How similar studies have performed: Previous research has shown promise in developing filtration technologies for water contaminants, but this specific approach to arsenic removal is innovative and addresses existing gaps.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CORONELL NIETO, ORLANDO — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: CORONELL NIETO, ORLANDO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers